What is the evidence for the use of Low Molecular Weight Heparins for the prophylaxis of travel-related thrombosis?

This Medicines Q&A evaluates the evidence for using low molecular weight heparins for the prevention of travel-related venous thromboembolism

Retaining PGD documentation

PGD documentation includes master authorised (signed) copies of PGDs, lists of authorised practitioners and patient supply/administration records, including electronic records/agreements. The same rules apply to…

Patient Group Directions in Complex Commissioning Scenarios

Commissioning of NHS and publically funded health services has become increasingly complex with many services provided by a number of providers with sub-contracting or sub-commissioning…

What injections can be given enterally?

This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…

What factors need to be considered when dosing patients with renal impairment?

Many commonly used drugs or their metabolites are excreted by the kidney, and this has particular significance for people with renal impairment (RI). Impaired renal…

Switching from modified release doxazosin to standard release doxazosin in patients with hypertension

In 2017, NHS England published a document advising prescribers to switch doxazosin XL to standard release doxazosin. This is because doxazosin XL has a significantly…

Patient Group Directions (PGDs) for administration of contrast media in radiology services and exemplar PGD templates

This guide has been written in response to the many enquiries that we have received about the development and use of PGDs in radiology services.…

Glucosamine - what are the adverse effects?

This updated Medicines Q&A describes the adverse effects associated with the use of glucosamine.

Which oral antihistamines are safe to use whilst breastfeeding?

This updated UKMi Q & A looks at the use of non-sedating and sedating antihistamines during breastfeeding Summary There are very limited studies or case…

How can we minimise the risks to patients when using intravenous phenytoin in status epilepticus (SE)?

Intravenous phenytoin is one of a number of treatments that can be used to manage status epilepticus (SE); this is a condition where a convulsive…